Skip to main content
Smart Investors Daily
AptarGroup, Inc. logo

NYSE · ATR

AptarGroup, Inc.

Healthcare · Medical - Instruments & Supplies

$146.86

Down-$4.39 (-2.99%)

Updated Nov 5, 2026, 5:44 PM

SID Score

6.5/10

Composite research score

Smart Money

58/100

Neutral

Market cap
7.8B
P/E ratio
18.57
Dividend yield
1.25%
52-week range
$108.29 – $146.91
Volume
672.47K
Avg. volume
553.94K

Price performance · ATR

ATR price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

ATR closed at $146.86 after 21 trading sessions, up 21.95% for the selected period.

Last close
$146.86
Period change
+21.95%
Period low
$118.95
Period high
$146.86
Daily close
View OHLC price history
ATR OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 4, 2026$143.30$147.21$142.27$146.86672.47K
Nov 3, 2026$143.44$144.24$141.241$142.31668.81K
Nov 2, 2026$137.00$144.03$136.39$143.86882.43K
Oct 30, 2026$138.59$142.31$135.52$137.201.01M
Oct 29, 2026$128.63$131.025$128.355$130.64649.74K
Oct 28, 2026$125.58$127.32$125.00$127.17449.26K
Oct 27, 2026$126.06$127.4525$125.315$126.51445.28K
Oct 26, 2026$126.77$127.6799$126.50$127.07370.66K
Oct 23, 2026$126.90$127.71$125.57$126.55354.36K
Oct 22, 2026$125.66$128.715$124.83$128.10426.36K
Oct 21, 2026$125.90$126.535$125.49$125.63448.49K
Oct 20, 2026$124.49$126.01$124.0194$125.77356.89K
Oct 19, 2026$123.96$125.47$123.39$124.63277.48K
Oct 16, 2026$125.08$125.985$124.175$124.51550.21K
Oct 15, 2026$122.51$124.95$122.51$124.26359.53K
Oct 14, 2026$119.55$120.31$118.5601$120.27452.11K
Oct 13, 2026$120.21$120.625$118.34$119.21795.7K
Oct 12, 2026$120.21$121.03$118.87$118.95476.76K
Oct 9, 2026$121.47$121.52$119.5001$120.38542.18K
Oct 8, 2026$119.93$122.42$119.91$121.81602.4K
Oct 7, 2026$121.17$121.325$119.8592$120.43605.91K

Latest ATR news

The latest Smart Investors Daily articles mentioning ATR.

ATR research

Overview

Company profile and research snapshot.

Company profile

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$139.00
Implied upside
—
Analysts
—
ATR recent ratings
DateFirmRatingTarget
Oct 9, 2026UBSNeutral—
Aug 3, 2026Wells FargoOverweight—
May 4, 2026Wells FargoOverweight—
Mar 20, 2026Wells FargoOverweight—
Jan 6, 2026Wells FargoEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 30, 2026

What AptarGroup (ATR) Said on Its Q3 Earnings Call

AptarGroup (NYSE:ATR) reported third-quarter 2026 sales growth across its three business segments, while adjusted profitability declined from the prior year as emergency medicine destocking and lower margins in Beauty and Closures weighed on results. Reported sales rose 6% to just over $1 billion,

Benzinga · Oct 30, 2026

AptarGroup Q3 2026 Earnings Call Transcript

AptarGroup (NYSE:ATR) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.